CPSC recall 23154
Nurtec® ODT (rimegepant) orally disintegrating tablets, 75mg 8-Unit Dose blister pack
- CPSC
- unknown
- Published 2023-03-16
On 2023-03-16 the CPSC announced a recall of Nurtec® ODT (rimegepant) orally disintegrating tablets, 75mg 8-Unit Dose blister pack by Biohaven Pharmaceuticals, citing the recalled prescription drugs must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the products is not child resistan….
| Agency | CPSC |
|---|---|
| Recall number | 23154 |
| Classification | Not classified |
| Status | unknown |
| Initiated | 2023-03-16 |
| Published | 2023-03-16 |
| Last updated | 2026-09-13 11:58 UTC |
| Company | Biohaven Pharmaceuticals |
| Distribution | US |
Product
Nurtec® ODT (rimegepant) orally disintegrating tablets, 75mg 8-Unit Dose blister pack | This recall involves prescription drugs Nurtec ODT 75 mg orally disintegrating tablets sold in cartons containing one blister card of 8 tablets. The tablets are in a non-child resistant blister card packaged in a carton that includes the name of the product, dosage strength, expiration date. The dosage strength and expiration date are printed or stamped on the blister card. The recall includes the following: Product Description NDC Number Expiration Date Nurtec® ODT (rimegepant) 75mg 8-Unit Dose blister pack 72618-3000-2 All dates through 6/2026
Reason
The recalled prescription drugs must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the products is not child resistant, posing a risk of poisoning if the contents are swallowed by young children.
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:58 UTC. Current status: unknown.
Source
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.